Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Degeneration Nonexudative”

203 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 203 results

Not applicableLooking for participantsNCT04847635
What this trial is testing

Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration

Who this might be right for
Macular Degeneration, SenileLaser Burn of RetinaMacular Degeneration Intermediate+1 more
Ospedale San Raffaele 50
Testing effectiveness (Phase 2)Looking for participantsNCT06659549
What this trial is testing

Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

Who this might be right for
Geographic Atrophy of the Macula
Galimedix Therapeutics Inc 110
Testing effectiveness (Phase 2)Study completedNCT01445548
What this trial is testing

Sirolimus for Advanced Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationGeographic Atrophy
National Eye Institute (NEI) 6
Not applicableStudy completedNCT01692938
What this trial is testing

Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO

Who this might be right for
Age-Related Macular DegenerationGeographic AtrophyDiabetic Retinopathy+6 more
Optos, PLC 32
Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Testing effectiveness (Phase 2)Looking for participantsNCT06990269
What this trial is testing

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
ADARx Pharmaceuticals, Inc. 240
Not applicableEnded earlyNCT00599846
What this trial is testing

The Natural History of Geographic Atrophy Progression (GAP) Study

Who this might be right for
Age-Related Macular DegenerationGeographic Atrophy
Alcon Research 1,000
Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Early research (Phase 1)Study completedNCT04014777
What this trial is testing

Study of NGM621 in Participants With Geographic Atrophy

Who this might be right for
Geographic Atrophy
NGM Biopharmaceuticals, Inc 15
Early research (Phase 1)Study completedNCT04246866
What this trial is testing

First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyMacular Degeneration+2 more
Gemini Therapeutics, Inc. 12
Not applicableLooking for participantsNCT06375239
What this trial is testing

Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration

Who this might be right for
Retinitis PigmentosaChoroideremiaStargardt Macular Dystrophy+4 more
Ray Therapeutics, Inc. 120
Testing effectiveness (Phase 2)Looking for participantsNCT07158775
What this trial is testing

Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD

Who this might be right for
Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)
Bionic Sight LLC 40
Testing effectiveness (Phase 2)Study completedNCT02613572
What this trial is testing

Alpha Lipoic Acid in Geographic Atrophy

Who this might be right for
Age-Related Macular Degeneration
University of Pennsylvania 68
Not applicableLooking for participantsNCT01866371
What this trial is testing

High Resolution Retinal Imaging

Who this might be right for
StargardtsRetinitis PigmentosaAge-related Macular Degeneration+2 more
University of Pennsylvania 600
Testing effectiveness (Phase 2)Study completedNCT02503332
What this trial is testing

Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy

Who this might be right for
Geographic Atrophy
Apellis Pharmaceuticals, Inc. 246
Not applicableStudy completedNCT01256827
What this trial is testing

Seven Year Update of Macular Degeneration Patients

Who this might be right for
Age-related Macular Degeneration
University of California, San Francisco 65
Testing effectiveness (Phase 2)Ended earlyNCT04437368
What this trial is testing

EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

Who this might be right for
Dry Age-related Macular Degeneration
Gyroscope Therapeutics Limited 98
Not applicableStudy completedNCT05891275
What this trial is testing

Patients With Geographic Atrophy and Their Patient Journey in the United States (US)

Who this might be right for
Geographic Atrophy
Boehringer Ingelheim 68,563
Not applicableNot Yet RecruitingNCT05418231
What this trial is testing

Observation of the Natural Course of Age-related Macular Degeneration

Who this might be right for
Dry Age-related Macular DegenerationMacular Degeneration, Dry
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 500
Testing effectiveness (Phase 2)Looking for participantsNCT06765980
What this trial is testing

Evaluate KRIYA-825 (VV-14295) in Adults With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Kriya Therapeutics, Inc. 62
Load More Results